Skip to main content
. 2020 Oct 7;64(1):119–128. doi: 10.1007/s00125-020-05287-1

Table 1.

Demographic, clinical and anthropometric characteristics by family history of type 1 diabetes (mother vs father vs sibling)

Variable Mother (n = 1046) Father (n = 722) Sibling (n = 306) p value
Male sex, n (%) 547 (52) 391 (54) 156 (51) NS
Birth ordera 1 (1) 1 (1) 2 (1) <0.001
Birthweight, kg 3.65 ± 0.60 3.56 ± 0.49 3.57 ± 0.49 0.004
Birth length, cm 50.9 ± 3.0 51.0 ± 2.4 51.6 ± 2.7 <0.001
Weight at 24 months, cm 12.8 ± 1.6 12.9 ± 1.4 12.9 ± 1.7 0.627
Weight at 24 months, z score 0.2 ± 1.1 0.3 ± 1.0 0.2 ± 1.2 0.346
BMI at 24 months, z score 0.08 ± 1.15 −0.03 ± 1.04 −0.15 ± 1.17 0.054
Height velocity at 24 months, cm/year 18.3 ± 2.0 18.5 ± 1.9 18.2 ± 1.8 0.053
Height velocity at 24 months, z score −0.04 ± 0.66 0.00 ± 0.61 −0.011 ± 0.56 0.041
bHLA risk type, n (%) 0.017
 HLA risk 1 229 (22) 171 (24) 95 (31)
 HLA risk 2 456 (44) 336 (47) 117 (38)
 HLA risk 3 350 (34) 210 (29) 92 (30)
 HLA risk 4 11 (1) 5 (1) 2 (1)
Length of exclusive breastfeeding, months 0.7 ± 1.6 1.8 ± 2.2 2.3 ± 2.3 <0.001
Caesarean section, n (%) 642 (61.4) 183 (25.3) 74 (24.2) <0.001
Gestational age, weeks 37.8 ± 1.3 39.8 ± 1.4 39.4 ± 1.4 <0.001
Autoantibodies, n (%)
 Multiple 107 (10) 114 (16) 56 (18) <0.001
 IAA 139 (13) 110 (15) 70 (23) <0.001
 GADA 154 (15) 126 (18) 66 (22) 0.015
 IA-2A 72 (7) 85 (12) 39 (13) <0.001
 ZnT8A 65 (6) 75 (10) 31 (10) 0.003
 ICA 337 (32) 270 (37) 117 (38) 0.034
Type 1 diabetes, n (%) 59 (6) 60 (8) 38 (12) <0.001
Follow-up time, years 9.1 ± 4.3 9.4 ± 4.0 8.7 ± 4.3 0.032

Values are expressed as mean±SD or n (%)

aValues are expressed as median (IQR)

bHLA risk 1, HLA-DQB1*02/DQB1*03:02; HLA risk 2, HLA-DQB1*03:02/x (x not DQB1*02, DQB1*03:01 or DQB1*06:02); HLA risk 3, HLA-DQA1*05-DQB1*02/y (y not DQA1*02:01-DQB1*02, DQB1*03:01, DQB1*06:02 or DQB1*06:03); HLA risk 4, HLA-DQA1*03-DQB1*02/y (y not DQA1*02:01-DQB1*02, DQB1*03:01, DQB1*06:02 or DQB1*06:03)